Medical diagnostics firm Ellume gets German backing for TB testing
7 January 2019, Peter Williams This article originally appeared in The Australian, print and online, on 7th January 2019. View the original here on The Australian Website. Brisbane medical diagnostics company Ellume has received a $US15 million ($21m) investment from German biotech Qiagen as part of a broader strategic partnership between the two companies to detect tuberculosis. Clinical trials for a […]
Read More
